Loma Therapeutics joins BioInnovation Institute’s (BII) Venture Lab program with a mission to revolutionize HPV cancer treatment and to address the pressing global health crisis posed by HPV-related cancers.
Participation in BII’s Venture Lab program provides Loma Therapeutics with vital support and resources to achieve key milestones, including defining a target product profile and conducting head-to-head studies against competitors. Through collaboration within the BII community and access to expert guidance, Loma Therapeutics is poised to make a significant impact in the fight against HPV disease.
Read more at: https://bii.dk/news/meet-the-start-ups-loma-therapeutics/